HomeWebinarsModel-Informed Drug Discovery and Development (MID3): Transforming strategic decision making in oncology

Webinar

Model-Informed Drug Discovery and Development (MID3): Transforming strategic decision making in oncology
Date & Time: May 9, 2026 | 13:00 - 14:00
Summary

Summary text – scientists and collaborators open the doors to real projects and real decision-making — showing how Quantitative Systems Pharmacology (QSP) and toxicology, population PK/PD, exposure-response, PBPK, MBMA, and AI/ML methods are used in practice to address critical questions of translation, dose selection, biomarker strategy, and clinical trial design.
This is your opportunity to see how quantitative modeling drives development decisions and to learn from the teams who apply these approaches in day-to-day work: decisions and to learn from the teams who apply these approaches in day-to-day work:owing how Quantitative Systems Pharmacology (QSP) and toxicology, population PK/PD,

read more →
Registration form:
Kirill Peskov, PHD
Speaker
Kirill Peskov, PHD
CEO, M&S Decisions
Webinar focus
Application of QSP in support of translational studies, next-generation MABEL FIH dose estimation and design of early clinical trials.
How mechanistic PK/PD modeling and Model-Based Meta-Analysis support dose finding and personalization in the framework of "Project Optimus" initiative.
Discussion of modeling application for support of rational design of late-phase clinical trials.